
Neovasc NVCN
Annual report 2021
added 12-23-2023
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
63 M |
Market Cap[1] |
$ 111 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
$ 10.89 | -0.11 % | $ 1.63 B | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | - | $ 38 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.98 | 0.06 % | $ 1.47 B | Nasdaq Capital Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Align Technology
ALGN
|
$ 173.12 | -0.01 % | $ 13 B | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.5 | 2.71 % | $ 1.69 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 282.0 | 1.03 % | $ 7.96 B | NYSE,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.33 | 0.91 % | $ 125 M | Nasdaq Global Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 37.77 | 0.48 % | $ 5.63 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 61.78 | 0.03 % | $ 91.5 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 8.7 | 0.25 % | $ 246 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 24.12 | - | $ 204 M | NYSE American | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 1.86 | -1.59 % | $ 1.13 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Inogen
INGN
|
$ 6.34 | 0.16 % | $ 169 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 0.99 | -0.99 % | $ 16.8 M | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.89 | -0.5 % | $ 373 M | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 62.12 | -1.05 % | $ 3.39 B | Nasdaq Global Select Market | ||
|
Globus Medical
GMED
|
$ 90.52 | 0.17 % | $ 12.2 B | NYSE,SPB | ||
|
LENSAR
LNSR
|
$ 5.59 | -1.93 % | $ 66.8 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.13 | 0.61 % | $ 874 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 10.4 | 3.59 % | $ 373 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.69 | 0.51 % | $ 28.9 M | NYSE American | ||
|
Inspire Medical Systems
INSP
|
$ 53.9 | -0.19 % | $ 1.58 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 36.26 | -1.31 % | $ 1.13 B | NYSE,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 84.8 | -0.4 % | $ 2.95 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.65 | -0.16 % | $ 122 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.